The histamine releasing activity of the industrial agent--Fasavin E4
Bańkowska, K.; Kazimierczak, W.; Adamas, B.
Archivum Immunologiae et Therapiae Experimentalis 30(5-6): 353-356
1982
ISSN/ISBN: 0004-069X PMID: 6191734 Document Number: 189305
The effect of an industrial agent--Fasavin E4, on isolated rat mast cells has been investigated. It was shown that Fasavin E4 released histamine in concentration dependent fashion. The reaction was neither calcium nor energy dependent. It is concluded that histamine release induced by Fasavin E4 does not conform to secretion and possibly occurred due to membrane damage by cytolytic process.
Document emailed within 1 workday
Related Documents
Lindl, T.; Heinl-Sawaya, M.C.; Cramer, H. 1976: Effects of compound 48/80, a histamine-releasing agent, on accumulation and release of cyclic AMP in various regions of rat brain in vitro Research Communications in Chemical Pathology and Pharmacology 13(1): 65-74Thueson, D.O.; Speck, L.S.; Lett-Brown, M.A.; Grant, J.A. 1979: Histamine-releasing activity (HRA). II. Interaction with basophils and physicochemical characterization Journal of Immunology 123(2): 633-639
Murmann, W.; Carminati, G.M.; Cattaneo, R. 1974: Pharmacology of zolimidine (2-(p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine) a new non-anticholinergic gastroprotective agent. III). Gastric antisecretory activity, antagonism against acid hypersecretion induced by pentagastrin and histamine, and other effects Panminerva Medica 16(10): 335-346
Jedra, M. 1992: Effect of histamine application on diamine oxidase activity in kidneys and histamine level in urine Roczniki Panstwowego Zakladu Higieny 43(3-4): 277-279
Zingel, V.; Elz, S.; Schunack, W. 1992: Histamine analogues. 36th communication. Basically substituted histamine derivatives with H1-agonistic activity Die Pharmazie 47(10): 746-751
Fjellner, B.; Hägermark, O. 1981: Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters Acta Dermato-Venereologica 61(3): 245-250
Deline, T.R.; Eyre, P.; Wells, P.W. 1973: Histamine releasing properties of the anthelmintic, 1-diethylcarbamyl-4-methylpiperazine citrate, (diethylcarbamazine) Archives Internationales de Pharmacodynamie et de Therapie 205(1): 192-198
Schunack, W. 1978: Histamine analogues with nicotine-like action. 11th communication: Structure-activity relationships among histamine analogues Arzneimittel-Forschung 28(12): 2199-2202
Eriks, J.C.; van der Goot, H.; Timmerman, H. 1993: New activation model for the histamine H2 receptor, explaining the activity of the different classes of histamine H2 receptor agonists Molecular Pharmacology 44(4): 886-894
Tedeschi, A.; Lorini, M.; Suli, C.; Cugno, M. 2007: Detection of serum histamine-releasing factors in a patient with idiopathic anaphylaxis and multiple drug allergy syndrome Journal of Investigational Allergology and Clinical Immunology 17(2): 122-125
Koller, W. 1988: Rapid disinfection of surfaces with a chlorine-releasing scouring agent Zentralblatt für Bakteriologie Mikrobiologie und Hygiene. Serie B Umwelthygiene Krankenhaushygiene Arbeitshygiene Praventive Medizin 185(4-5): 411-420
Tanaka, H. 1985: Histamine release due to ganglion blocking agent and muscle relaxants from rat mast cells Hokkaido Journal of Medical Science 60(2): 273-281
Grzelewska-Rzymowska, I.; Grzegorczyk, J.; Kroczyńska-Bednarek, J.; Grabski, W.; Kuźmińska, B.; Rozniecki, J. 1997: The effect of nedocromil sodium on spontaneous production of histamine releasing factor (HRF) by mononuclear blood cells in patients with nonatopic bronchial asthma Pneumonologia i Alergologia Polska 65(11-12): 775-782
Takahashi, M. 1988: Experimental study of anti-tumor agent microcapsules--the effects of embolization and drug releasing Nihon Geka Gakkai Zasshi 89(5): 684-693
Holroyde, M.C.; Eyre, P. 1978: Histamine enhances anaphylactic histamine release from bovine lung and leukocytes via histamine H2-receptor Journal of Pharmacology and Experimental Therapeutics 204(1): 183-188
Basta, S.J.; Savarese, J.J.; Ali, H.H.; Moss, J.; Gionfriddo, M. 1983: Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine British Journal of Anaesthesia 55(Suppl 1): 105s-106s
Bulycheva, N.A.; Ekinova, G.M.; Vasil'eva, T.G. 1998: Clinical trial of a new topical anti-histamine agent histimet in the treatment of seasonal allergic rhinoconjunctivitis Vestnik Otorinolaringologii 3: 46-48
Nikanorova, S.A.; Kononova, E.S.; Chembartseva, A.N. 1982: Sensitivity of the pituitary gland to LH-FSH releasing hormone in women after discontinuation of ovidon, an estrogen-progesterone contraceptive agent Akusherstvo i Ginekologiia 10: 40-41
Kaewruttanapattama, F.; Chokboonpium, J.; Thammahong, A.; Klaewsongkram, J. 2010: A comparison between morphine and histamine as a positive control agent for intradermal skin testing: an evidence-based study Journal of Investigational Allergology and Clinical Immunology 20(7): 626-627
Nakazawa, M.; Yoshimura, T.; Naito, J.; Azuma, H. 1978: Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent. (5).--Influence of N-5' on the histamine release from peritoneal exudate cells Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 74(4): 483-490